RecruitingNCT06472804
Insomnia in Patients With Metastatic Lung Cancer
Insomnia in Patients With Metastatic Non Small Cell Lung Cancer
Sponsor
Mayo Clinic
Enrollment
60 participants
Start Date
Jun 19, 2019
Study Type
OBSERVATIONAL
Conditions
Summary
This study evaluates how common insomnia (difficulties with sleep) is in patients with lung cancer that has spread from where it first started (primary site) to other places in the body.
Eligibility
Min Age: 18 Years
Plain Language Summary
Simplified for easier understanding
This study is looking at insomnia (trouble sleeping) in people with metastatic non-small cell lung cancer (lung cancer that has spread to other parts of the body). Researchers want to better understand how common sleep problems are in this group, how they affect quality of life, and what might help.
**You may be eligible if...**
- You have been diagnosed with metastatic non-small cell lung cancer
- You are receiving your 1st, 2nd, or 3rd round of treatment, or are on maintenance therapy
- You are older than 18 years old
**You may NOT be eligible if...**
- Your cancer is considered advanced and terminal
- You have severe depression or another psychiatric disorder
- You have a sleep disorder other than insomnia (such as sleep apnea or restless leg syndrome)
- You regularly take certain psychiatric medications (other than sleep aids)
Talk to your doctor to see if this trial is right for you.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
OTHERNon-Interventional Study
Non-interventional study
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06472804
Related Trials
Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer
NCT04181060603 locations
Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial
NCT06096844318 locations
Testing the Combination of an Anti-cancer Drug, Iadademstat, With Other Anti-cancer Drugs (Atezolizumab or Durvalumab) at Improving Outcomes for Small Cell Lung Cancer
NCT0628777543 locations
Morning Versus Afternoon Administration of Immunotherapy for the Treatment of Advanced or Metastatic Solid Tumors, The Knight SHIFT Study
NCT074050861 location
Avapritinib for the Treatment of CKIT or PDGFRA Mutation-Positive Locally Advanced or Metastatic Malignant Solid Tumors
NCT047715201 location